1. Home
  2. OLMA vs NEXN Comparison

OLMA vs NEXN Comparison

Compare OLMA & NEXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • NEXN
  • Stock Information
  • Founded
  • OLMA 2006
  • NEXN 2007
  • Country
  • OLMA United States
  • NEXN Israel
  • Employees
  • OLMA N/A
  • NEXN N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • NEXN Computer Software: Programming Data Processing
  • Sector
  • OLMA Health Care
  • NEXN Technology
  • Exchange
  • OLMA Nasdaq
  • NEXN Nasdaq
  • Market Cap
  • OLMA 725.5M
  • NEXN 636.1M
  • IPO Year
  • OLMA 2020
  • NEXN 2021
  • Fundamental
  • Price
  • OLMA $8.48
  • NEXN $6.48
  • Analyst Decision
  • OLMA Strong Buy
  • NEXN Strong Buy
  • Analyst Count
  • OLMA 6
  • NEXN 9
  • Target Price
  • OLMA $23.00
  • NEXN $12.13
  • AVG Volume (30 Days)
  • OLMA 969.7K
  • NEXN 434.5K
  • Earning Date
  • OLMA 11-10-2025
  • NEXN 11-13-2025
  • Dividend Yield
  • OLMA N/A
  • NEXN N/A
  • EPS Growth
  • OLMA N/A
  • NEXN 237.45
  • EPS
  • OLMA N/A
  • NEXN 0.62
  • Revenue
  • OLMA N/A
  • NEXN $376,353,000.00
  • Revenue This Year
  • OLMA N/A
  • NEXN $5.43
  • Revenue Next Year
  • OLMA N/A
  • NEXN N/A
  • P/E Ratio
  • OLMA N/A
  • NEXN $10.35
  • Revenue Growth
  • OLMA N/A
  • NEXN 7.80
  • 52 Week Low
  • OLMA $2.86
  • NEXN $6.08
  • 52 Week High
  • OLMA $11.54
  • NEXN $12.60
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 49.32
  • NEXN 27.66
  • Support Level
  • OLMA $7.82
  • NEXN $6.08
  • Resistance Level
  • OLMA $8.80
  • NEXN $8.05
  • Average True Range (ATR)
  • OLMA 0.61
  • NEXN 0.32
  • MACD
  • OLMA -0.02
  • NEXN -0.15
  • Stochastic Oscillator
  • OLMA 41.57
  • NEXN 16.67

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About NEXN Nexxen International Ltd. American Depository Shares

Nexxen International Ltd is a globalized and flexible advertising technology platform with deep expertise in data and advanced TV that helps empower advertisers, agencies, digital publishers and broadcasters to achieve desired outcomes, including increased efficiency and returns, across the media supply chain. It is a demand-side platform (DSP), supply-side platform (SSP), ad server, and data management platform (DMP) and also delivers a flexible and unified technology stack with and exclusive data at its core. Company operates in America, APAC, EMEA, regions, with majority revenue from America.

Share on Social Networks: